Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 5, 2011, Pages 811-819

  Schwarzenbach, Heidi ^a   Chun, Felix K H ^a   Isbarn, Hendrik ^a   Huland, Hartwig ^a   Pantel, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Circulating cell free DNA; Copy number; DNA methylation; Tumor suppressor genes

Indexed keywords

DNA;

ADULT; AGED; APC GENE; ARTICLE; CD44 GENE; CDKN2A GENE; CHFR GENE; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; DNA SEQUENCE; E CADHERIN GENE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GSTP1 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PTEN GENE; TP73 GENE; VALIDITY;

AGED; ANTIGENS, CD44; BONE MARROW; CADHERINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE;

EID: 79955688833     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0941-5     Document Type: Article

References (29)

1. Algaba F, Trias I, Arce Y (2007) Natural history of prostatic carcinoma: the pathologist's perspective. Recent Results Cancer Res 175:9-24
2. Blanco-Aparicio C, Renner O, Leal JF, Carnero A (2007) Pten, more than the akt pathway. Carcinogenesis 28(7):1379-1386 (Pubitemid 47243536)
3. Brewster SF, Browne S, Brown KW (1994) Somatic allelic loss at the dcc, apc, nm23-h1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J Urol 151(4):1073-1077 (Pubitemid 24083517)
4. Chun FK, Muller I, Lange I, Friedrich MG, Erbersdobler A, Karakiewicz PI, Graefen M, Pantel K, Huland H, Schwarzenbach H (2006) Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer. BJU Int 98(3):544-548 (Pubitemid 44185873)
5. Costa VL, Henrique R, Jeronimo C (2007) Epigenetic markers for molecular detection of prostate cancer. Dis Markers 23(1-2):31-41 (Pubitemid 46333639)
6. Fehm T, Sagalowsky A, CliVord E, Beitsch P, Saboorian H, Euhus D, Meng S, Morrison L, Tucker T, Lane N, Ghadimi BM, Heselmeyer- Haddad K, Ried T, Rao C, Uhr J (2002) Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 8(7):2073-2084 (Pubitemid 34753576)
7. Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, Pantel K, Solomayer E (2006) A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 107(5):885-892 (Pubitemid 44291136)
8. Fleischhacker M, Schmidt B (2007) Circulating nucleic acids (cnas) and cancer - a survey. Biochim Biophys Acta 1775(1):181-232 (Pubitemid 44911084)
9. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA (2007) A switch from e-cadherin to n-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13(23):7003-7011 (Pubitemid 350276881)
10. Hanley R, Rieger-Christ KM, Canes D, Emara NR, Shuber AP, Boynton KA, Libertino JA, Summerhayes IC (2006) DNA integrity assay: a plasma-based screening tool for the detection of prostate cancer. Clin Cancer Res 12(15):4569-4574 (Pubitemid 44297806)
11. Kito H, Suzuki H, Ichikawa T, Sekita N, Kamiya N, Akakura K, Igarashi T, Nakayama T, Watanabe M, Harigaya K, Ito H (2001) Hypermethylation of the cd44 gene is associated with progression and metastasis of human prostate cancer. Prostate 49(2):110-115 (Pubitemid 32937806)
12. Klein CA (2006) Random mutations, selected mutations: a pin opens the door to new genetic landscapes. Proc Natl Acad Sci USA 103(48):18033-18034
13. Kollermann J, Weikert S, Schostak M, KempkensteVen C, Kleinschmidt K, Rau T, Pantel K (2008) Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment. J Clin Oncol 26(30): 4928-4933
14. Muller I, Urban K, Pantel K, Schwarzenbach H (2006) Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia. Ann N Y Acad Sci 1075:222-229 (Pubitemid 44532788)
15. Muller I, Beeger C, Alix-Panabieres C, Rebillard X, Pantel K, Schwarzenbach H (2008) Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements. Clin Chem 54(4):688-696 (Pubitemid 351573708)
16. Nygren AO, Ameziane N, Duarte HM, Vijzelaar RN, Waisfisz Q, Hess CJ, Schouten JP, Errami A (2005) Methylation-specific mlpa (ms-mlpa): simultaneous detection of cpg methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 33(14):e128
17. Pantel K, BrakenhoV RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4(6):448-456 (Pubitemid 38745530)
18. Pantel K, BrakenhoV RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8(5):329-340 (Pubitemid 351596394)
19. Pena C, Garcia JM, Dominguez G, Silva J, Garcia V, Carcereny E, Vargas J, Provencio M, Espana P, Bonilla F (2004) Intronic deletion aVecting a negative regulatory region of tp73 is related to breast and colorectal carcinomas. Genes Chromosomes Cancer 39(3):257-262 (Pubitemid 38209586)
20. Perinchery G, Bukurov N, Nakajima K, Chang J, Li LC, Dahiya R (1999) High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer. Int J Cancer 83(5):610-614 (Pubitemid 29508038)
21. Saric T, Brkanac Z, Troyer DA, Padalecki SS, Sarosdy M, Williams K, Abadesco L, Leach RJ, O'Connell P (1999) Genetic pattern of prostate cancer progression. Int J Cancer 81(2):219-224 (Pubitemid 29144750)
22. Schwarzenbach H, Chun FK, Lange I, Carpenter S, Gottberg M, Erbersdobler A, Friedrich MG, Huland H, Pantel K (2007) Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer. Int J Cancer 120(7):1465-1471 (Pubitemid 46355381)
23. Schwarzenbach H, Chun FK, Muller I, Seidel C, Urban K, Erbersdobler A, Huland H, Pantel K, Friedrich MG (2008) Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer. BJU Int 102(2):253-258 (Pubitemid 351852597)
24. Schwarzenbach H, Alix-Panabieres C, Muller I, Letang N, Vendrell JP, Rebillard X, Pantel K (2009) Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 15(3):1032-1038
25. Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chen XQ, Anker P (2000) The origin and mechanism of circulating DNA. Ann N Y Acad Sci 906:161-168 (Pubitemid 30255476)
26. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P (2001) About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 313(1-2): 139-142 (Pubitemid 33016703)
27. Sunami E, Shinozaki M, Higano CS, Wollman R, DorV TB, Tucker SJ, Martinez SR, Singer FR, Hoon DS (2009) Multimarker circulating DNA assay for assessing blood of prostate cancer patients. Clin Chem 55(3):559-567
28. Tamura G (2006) Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 12(2):192-198
29. Weckermann D, Polzer B, Ragg T, Blana A, Schlimok G, Arnholdt H, Bertz S, Harzmann R, Klein CA (2009) Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer. J Clin Oncol 27(10):1549-1556